The Medical Technology Enterprise Consortium (MTEC) is an enterprise partnership in collaboration with industry and academia to facilitate research and development activities, in cooperation with the U.S. Army Medical Research and Development Command (USAMRDC) and other Government agencies in the biomedical sciences (including but not limited to drugs, biologics, vaccines, medical software and medical devices) to protect, treat and optimize the health and performance of U.S. military personnel. MTEC is a nonprofit corporation with the following principal objectives: (a) biomedical research and prototyping; (b) exploration of private sector technology opportunities; (c) technology transfer; and (d) deployment of intellectual property (IP) and follow-on production.
This solicitation, issued by the MTEC Consortium Manager (CM), Advanced Technology International (ATI), represents a Request for Project Proposals (RPP) for MTEC support of the USAMRDC Military Infectious Disease Research Program (MIDRP). Military relevance is a critical component of the Proposal submission Strategic oversight for the award(s) supported by this RPP will be provided by the MIDRP staff and Joint Program Committee (JPC)-2.
The goal of this “Military Infectious Disease - Prototype Innovation Program (MID-PIP)” is to develop the following 4 prototypes:
- FOCUS AREA #1 (Diagnostic): A point-of-care device to detect the presence of microbial infection.
- FOCUS AREA #2 (mAbs): Generation of high affinity monoclonal antibodies to four bacterial antigens for the prevention and treatment of bacterial wound infections and sepsis.
- FOCUS AREA #3 (HIV): A single administration escape-resistant therapy for HIV control.
- FOCUS AREA #4 (Biofilm): Clinical evaluation of products to treat biofilm-mediated antibiotic-resistant infections in non-healing chronic wounds.
Proposal Due Date: September 16, 2019